Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05731622 | Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC(SINCERE) | recruiting | — | 100 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT05302284 | A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma | recruiting | Phase 3 | 452 | RemeGen Co., Ltd.INDUSTRY | 1 | Dec 18, 2023 |
| clinicaltrials |
| NCT06170177 | Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy | recruiting | — | 4,000 | IRCCS San RaffaeleOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT06169436 | Translational Cancer Observational Protocol | recruiting | — | 1,250 | IRCCS San RaffaeleOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT06167356 | Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. | recruiting | — | 20,000 | IRCCS San RaffaeleOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT06116396 | Liquid Biospy for Urinary Cancers(CIRCE) | recruiting | — | 450 | IRCCS San RaffaeleOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06116019 | Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)(ART-02) | recruiting | — | 649 | Charite University, Berlin, GermanyOTHER | 1 | Nov 3, 2023 | clinicaltrials |
| NCT05899361 | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | recruiting | N/A | 10 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT03216525 | Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol | recruiting | Phase 3 | 136 | Brigham and Women's HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03379909 | Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer(TROJAN) | recruiting | Phase 2 | 49 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05600127 | Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer(CHASIT) | recruiting | Phase 2 | 64 | Erasmus Medical CenterOTHER | 1 | Sep 8, 2023 | clinicaltrials |
| NCT06026189 | Safely Reduce Cystoscopic Evaluations for Hematuria Patients(SeARCH) | recruiting | N/A | 1,100 | Erasmus Medical CenterOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT06009510 | Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer | not yet recruiting | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05943379 | RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects | recruiting | Phase 2 | 85 | RemeGen Co., Ltd.INDUSTRY | 1 | Jul 13, 2023 | clinicaltrials |
| NCT04617756 | Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract(iNDUCT) | recruiting | Phase 2 | 50 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05810623 | Single-Dose Intravesical Chemotherapy After Diagnostic URS(MINERVA) | not yet recruiting | Phase 3 | 394 | David D'AndreaOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05715684 | Patient-Centered Surgical Prehabilitation(Prehab) | recruiting | N/A | 25 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05733000 | CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors | recruiting | Phase 2 | 94 | Northwestern UniversityOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT04625556 | Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT04186013 | Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer | active not recruiting | Phase 2 | 39 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05415631 | Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence(Bladder-PAD) | recruiting | — | 500 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT05325216 | Urinary Continence of Female POPRC and OIN | not yet recruiting | N/A | 58 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 13, 2022 | clinicaltrials |
| NCT03836352 | Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors | active not recruiting | Phase 2 | 184 | ImmunoVaccine Technologies, Inc. (IMV Inc.)INDUSTRY | 2 | Mar 31, 2022 | clinicaltrials |
| NCT04947059 | Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)(GENSA) | recruiting | Phase 3 | 180 | University of ThessalyOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT05072600 | Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer | recruiting | Phase 2 | 54 | Peking University First HospitalOTHER | 1 | Jan 10, 2022 | clinicaltrials |
| NCT03179943 | Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma | active not recruiting | Phase 2 | 21 | Fox Chase Cancer CenterOTHER | 1 | Nov 4, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04900558 | Robotic Radical Cystectomy Outcomes | recruiting | — | 500 | University of FlorenceOTHER | 1 | May 25, 2021 | clinicaltrials |
| NCT02447549 | Study of Tumour Focused Radiotherapy for Bladder Cancer(RAIDER) | active not recruiting | Phase 2 | 345 | Institute of Cancer Research, United KingdomOTHER | 3 | Jun 9, 2020 | clinicaltrials |
| NCT04197414 | Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT04167332 | Prospective Collection of Samples for Urothelial Cancer of Bladder(ProCSUCaB) | not yet recruiting | — | 630 | Universitaire Ziekenhuizen KU LeuvenOTHER | 0 | Nov 18, 2019 | clinicaltrials |
| NCT03698721 | Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate(IMOPU) | not yet recruiting | — | 365 | Central Hospital, Nancy, FranceOTHER | 0 | Oct 9, 2018 | clinicaltrials |
| NCT02489890 | CIK in Treating Patients With Bladder Cancer | active not recruiting | Phase 2 | 1,500 | The First People's Hospital of ChangzhouOTHER | 0 | Feb 22, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jan 31, 2024source: clinicaltrials